SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
1952489
Source:
http://linkedlifedata.com/resource/pubmed/id/1952489
Search
Subject
(
50
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005516
,
umls-concept:C0013203
,
umls-concept:C0026764
,
umls-concept:C1278052
,
umls-concept:C1850775
pubmed:issue
12
pubmed:dateCreated
1991-12-23
pubmed:abstractText
To evaluate serum lactate dehydrogenase (LDH) as a prognostic factor in previously untreated patients with multiple myeloma.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA-16672
,
http://linkedlifedata.com/resource/pubmed/grant/CA-28771
,
http://linkedlifedata.com/resource/pubmed/grant/CA-37161
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers
,
http://linkedlifedata.com/resource/pubmed/chemical/L-Lactate Dehydrogenase
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0003-4819
pubmed:author
pubmed-author:AlexanianRR
,
pubmed-author:BarlogieBB
,
pubmed-author:DimopoulosM AMA
,
pubmed-author:SmithT LTL
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
931-5
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:1952489-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:1952489-Biological Markers
,
pubmed-meshheading:1952489-Drug Resistance
,
pubmed-meshheading:1952489-Humans
,
pubmed-meshheading:1952489-Karyotyping
,
pubmed-meshheading:1952489-L-Lactate Dehydrogenase
,
pubmed-meshheading:1952489-Middle Aged
,
pubmed-meshheading:1952489-Multiple Myeloma
,
pubmed-meshheading:1952489-Ploidies
,
pubmed-meshheading:1952489-Prognosis
,
pubmed-meshheading:1952489-Proportional Hazards Models
,
pubmed-meshheading:1952489-Survival Analysis
,
pubmed-meshheading:1952489-Time Factors
pubmed:year
1991
pubmed:articleTitle
High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma.
pubmed:affiliation
University of Texas M. D. Anderson Cancer Center, Houston.
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't